Dong-A crowned with top prescription drug company

Dong-A Pharmaceutical posted the highest revenue in Korea’s prescription drug market last year, with 471.6 billion won in terms of EDI claims, according to the Health Insurance Review and Assessment Service.

Thanks to robust sales of a homegrown drug Stillen and other flagship products, Dong-A’s prescription drug sales rose 7.2 percent last year from 2009.

Daewoong Pharmaceutical dropped ...